These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23348851)

  • 1. [Calculation of the first dose of amikacine: evaluation of the current dosage recommendations].
    Jean-Bart E; Debeurme G; Ducher M; Bourguignon L
    Ann Pharm Fr; 2013 Jan; 71(1):7-12. PubMed ID: 23348851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight].
    Bourguignon L; Goutelle S; Gérard C; Guillermet A; Burdin de Saint Martin J; Maire P; Ducher M
    Therapie; 2009; 64(1):47-53. PubMed ID: 19463252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity.
    Gálvez R; Luengo C; Cornejo R; Kosche J; Romero C; Tobar E; Illanes V; Llanos O; Castro J
    Int J Antimicrob Agents; 2011 Aug; 38(2):146-51. PubMed ID: 21612894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for aminoglycoside use and applicability to geriatric patients.
    Uhart M; Leroy B; Maire P; Bourguignon L
    Med Mal Infect; 2013 Mar; 43(3):118-22. PubMed ID: 23562282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M
    Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
    Taccone FS; de Backer D; Laterre PF; Spapen H; Dugernier T; Delattre I; Wallemacq P; Vincent JL; Jacobs F
    Int J Antimicrob Agents; 2011 Jun; 37(6):531-5. PubMed ID: 21489756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
    Pivot-Dumarest C; Deweerdt C; Troncy J; Sorensen P; Roux D; Maire P
    Pathol Biol (Paris); 1996 Apr; 44(4):299-305. PubMed ID: 8763595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
    Mareville J; Gay J; Cliquennois E; Herbaux C; Pasquier F; Allorge D; Blondiaux N; Berthon C; Alfandari S
    Scand J Infect Dis; 2012 May; 44(5):398-401. PubMed ID: 22235869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of the efficacy and safety of multiple daily doses of amikacin versus one daily dose for children with perforated appendicitis in Costa Rica.
    Pérez V; Saénz D; Madriz J; Harhay M; Feoli J; Castro M; Odio C
    Int J Infect Dis; 2011 Aug; 15(8):e569-75. PubMed ID: 21733727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.
    Jenkins A; Thomson AH; Brown NM; Semple Y; Sluman C; MacGowan A; Lovering AM; Wiffen PJ;
    J Antimicrob Chemother; 2016 Oct; 71(10):2754-9. PubMed ID: 27494904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.